Publicaciones en colaboración con investigadores/as de Hospital Universitario Araba (55)

2026

  1. Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

    Therapeutic Advances in Gastroenterology, Vol. 19

  2. Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC)

    Contact Dermatitis, Vol. 94, Núm. 6, pp. 614-623

  3. Designing interventions guided by digital phenotype and pharmacogenetics in Spain for suicidal behaviour based on retrospective data: the multicentre SMARTomicS study protocol

    BMJ Open , Vol. 16, Núm. 5

  4. Dietary Patterns in a Nationwide Cohort of Patients with Hereditary Fructose Intolerance

    Nutrients , Vol. 18, Núm. 5

  5. Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort

    Journal of the International AIDS Society, Vol. 29, Núm. 4

  6. Epidemiological, Clinical and Allergic Profile of Patients With Dyshidrotic Eczema (Acute and Recurrent Vesicular Dermatitis): Evaluation of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Contact Dermatitis

  7. Impact of Sleep-disordered Breathing Management in Primary Care on Systemic Hypertension Control: Protocol for the METASLEEP Implementation Trial

    Open Respiratory Archives, Vol. 8, Núm. 1

  8. Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients

    Clinical nutrition (Edinburgh, Scotland), Vol. 59, pp. 106608

  9. Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 5, pp. 690-709

  10. Nocturnal blood pressure patterns in pediatric obstructive sleep apnea: The Kids Trial study

    Sleep Medicine, Vol. 144

  11. Predicting early clinical recovery in first-episode psychosis: development and external validation of a clinically interpretable multivariable model

    British Journal of Psychiatry

  12. Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study

    Journal of Clinical Oncology

  13. Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry

    Cancer, Vol. 132, Núm. 8

  14. Understanding Adherence to Duloxetine in Psychiatric Practice: A Cross-Sectional Evaluation of Clinicians’ Experience

    Brain Sciences, Vol. 16, Núm. 2

2025

  1. A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

    Journal of Antimicrobial Chemotherapy, Vol. 80, Núm. 12, pp. 3438-3451

  2. Cardiovascular Risk Through Hypoxic Burden in Children with Sleep Apnea: A Secondary Analysis of a Nonrandomized Clinical Trial

    JAMA Network Open, Vol. 8, Núm. 10

  3. Comparing PANSS-6 and PANSS-30 for clinical and functional outcomes in first-episode psychosis: A 2-year follow-up in a Spanish cohort

    European Neuropsychopharmacology, Vol. 95, pp. 9-13

  4. Diagnostic Performance of a Type III Portable Monitoring Device for Obstructive Sleep Apnea in Pregnant Women: A Prospective Validation Study

    Journal of Women's Health, Vol. 34, Núm. 5, pp. 685-693

  5. Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol

    Clinical Infectious Diseases, Vol. 80, Núm. 2, pp. 371-380

  6. From Genetics to Psychosocial Functioning: Unraveling the Mediating Roles of Cognitive Reserve, Cognition, and Negative Symptoms in First-Episode Psychosis

    Acta Psychiatrica Scandinavica, Vol. 151, Núm. 5, pp. 600-612